Transcription of Next Generation Innovations in Regulatory Science
{{id}} {{{paragraph}}}
Example: barber
Next Generation Innovations in Regulatory Science
next Generation Innovations in Regulatory Science 28 October 2015 | Washington, DC. Better Science , Better Health Disclaimer The views and opinions expressed in the following PowerPoint slides are those of the individual presenter and should not be attributed to DIA, its directors, officers, employees, volunteers, members, chapters, councils, Communities or affiliates, or any organization with which the presenter is employed or affiliated. These PowerPoint slides are the intellectual property of the individual presenter and are protected under the copyright laws of the United States of America and other countries. Used by permission. All rights reserved. DIA and the DIA logo are registered trademarks or trademarks of Drug Information Association Inc.
Next Generation Innovations in Regulatory Science Panelists Hans-Georg Eichler, Senior Medical Officer, EMA Carol Linden, Director of Office of Regulatory Science and Innovation, US FDA Sandra Milligan, Senior Vice President and Head of Global Regulatory Affairs and Clinical Safety, Merck
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
Next Generation, X NEXT GENERATION SEALANT TECHNOLOGY, Regulatory Information, Next Generation Regulatory Information Management, Next Generation Regulatory Information Management and Intelligence, Regulatory, Regulatory Considerations for Next-Generation Sequencing, Regulatory Considerations for Next Generation Sequencing, Next, Generation, Next Generation Policy & Compliance, Information, Regulatory Framework for Next Generation, Next generation processing, KDHE, Designing Next Generation Telecom Regulation